Over the past five years the iShares Dow Jones U.S. Medical Devices Index Fund (IHI), which tracks the largest US medical device company stock performance, is outpacing the Dow Jones Industrial Average (+37% vs. +18% for the DJIA). Today, device manufacturers are certainly “enjoying” living among the ancient Chinese curse of “may you live in interesting times.” Recently, times have been difficult with the device tax, an almost constant stream of lawsuits, and product recalls. However, from a fundamental standpoint, the macroeconomic forces are still in place for medical device manufacturers to grow and profit. This report is intended to provide an overview of the medical device development market dynamics. Medical device manufacturers and their service providers can use the trial-specific data to benchmark their trial performance and use historic data to support and plan for future clinical development studies.

1. I EW
EV
PR
Medical Device: Clinical
Development Market
Assessment
Info@ISRreports.com ©2013 Industry Standard Research www.ISRreports.com

2. act with confidence
Report Overview
O
ver the past five years the iShares Dow Jones U.S. Medical Devices Index Fund (IHI), which tracks the largest
US medical device company stock performance, is outpacing the Dow Jones Industrial Average (+37% vs.
+18% for the DJIA).
Today, device manufacturers are certainly “enjoying” living among the ancient Chinese curse of “may you live in
interesting times.” Recently, times have been difficult with the device tax, an almost constant stream of lawsuits,
and product recalls. However, from a fundamental standpoint, the macroeconomic forces are still in place for
medical device manufacturers to grow and profit. This report is intended to provide an overview of the medical
device development market dynamics.
Medical device manufacturers and their service providers can use the trial-specific data to benchmark their trial
performance and use historic data to support and plan for future clinical development studies.
120 68 Q2
pages charts and graphs 2013 publication date
What you will learn in this report:
• Use historic Clinicaltrial.gov data to support and plan for future clinical development studies
• Benchmark study characteristics of 7,254 on-going or recently completed studies [All data are analyzed
by Phase and study type (i.e. interventional, observational, and expanded access)]
• Number of trials
• Length of trials
• Trial enrollment
• Selected sponsor distribution of trials
• Funding source distribution of trials
• Quantify the industry-funded clinical development market size (2010-2015)
• Receive full profiles of select medical device companies with active development pipelines
• Financial information
• Pipeline
• Recent patent activity
www.ISRreports.com ©2013 | Preview of: Medical Device: Clinical Development Market Assessment 2
2

3. act with confidence
Report Overview
Companies Analyzed:
• 3M • Dentsply International Inc. • Olympus
• Abbott Laboratories • Edwards Lifesciences • Siemens
• Allergan • Fresenius SE & Co • Smith & Nephew
• Bard • General Electric • Sorin Group
• Baxter International • Glaukos Corportation • St. Jude Medical Inc.
• Bayer AG • Hologic • Stryker
• Becton Dickenson • Hoya • Terumo
• Biomet Inc. • InSightec • Toshiba
• Biotronic SE & Co. KG • Johnson and Johnson (including • Ulthera Inc.
DePuy & Ethicon)
• Boston Scientific Corp. • Varian Medical Systems
• Koninklijke Philips Electronics
• Coloplast • W.L. Gore & Associates Inc.
• Medtronic Inc.
• Cook • Zimmer Holdings
• Merck KGaA
• Covidien
• Novartis AG
Major Sections:
1. Introduction
2. Executive Summary / Infographic
3. Clinical Trial Activity
4. Industry-funded Clinical Development Market Size
5. Medical Device Company Profiles
Valuable for:
Medical device companies, Contract research organizations (CROs), venture capital, and other medical device
service providers
www.ISRreports.com ©2013 | Preview of: Medical Device: Clinical Development Market Assessment 3
3

4. act with confidence
Table of Contents
Full Table of Contents available in the report preview:
http://bit.ly/ZxYyB0
www.ISRreports.com ©2013 | Preview of: Medical Device: Clinical Development Market Assessment 4
4

5. act with confidence
Sample Page
act with confidence
Average interventional trial length, by phase
The table represents the average number of months medical device interventional trials
took (recently completed trials) or are scheduled to take (ongoing trials) by their phase
of development. How to read the table: Ongoing medical device Phase I interventional
studies are projected to take, on average, 46 months to complete.
www.ISRreports.com ©2013 |©2013 | Medical Device:Device: Development Market Assessment Assessment
www.ISRreports.com Preview of: Medical Clinical Clinical Development Market 5 5
5

6. act with confidence
Ordering Information
Ordering information and additional sample pages are
available in the report preview:
http://bit.ly/ZxYyB0
About Industry Standard Research
Industry Standard Research (ISR) is the premier, full service market research provider to the pharma and
pharma services industries. With over a decade of experience in the industry, ISR delivers an unmatched
level of domain expertise.
For more information about our off-the-shelf intelligence and custom research offerings, please visit our
Web site at www.ISRreports.com, email info@ISRreports.com, or follow us on twitter @ISRreports.
www.ISRreports.com ©2013 | Preview of: Medical Device: Clinical Development Market Assessment 6
6